ZIVOW Zivo Bioscience, Inc.

Fundamentals / CIK 0001101026 / USD
Other share classes on CIK 0001101026: ZIVO

Zivo Bioscience, Inc. reported $209K in revenue and a net loss of $8.49M for the trailing twelve months ended September 30, 2025 (up 108.3% year over year), with a 31.7% gross margin and a -4045.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open ZIVOW in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2015 to 2024), reported in USD.

$1.70M$850K$0-$13.70MFY 2015 Revenue: $0FY 2015 Net Income: -$5.79M2015FY 2016 Revenue: $0FY 2016 Net Income: -$6.06M2016FY 2017 Revenue: $0FY 2017 Net Income: -$10.04M2017FY 2018 Revenue: $0FY 2018 Net Income: -$14.64M2018FY 2019 Revenue: $0FY 2019 Net Income: -$11.51M2019FY 2020 Revenue: $20KFY 2020 Net Income: -$9.11M2020FY 2021 Revenue: $0FY 2021 Net Income: -$8.76M2021FY 2022 Revenue: $0FY 2022 Net Income: -$8.75M2022FY 2023 Revenue: $28KFY 2023 Net Income: -$7.78M2023FY 2024 Revenue: $157KFY 2024 Net Income: -$13.38M2024

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $157K $28K $0 $0 $20K $0 $0 $0 $0 $0
Cost of Revenue $108K $16K $0 -- -- -- -- -- -- --
Gross Profit $49K $12K $0 -- -- -- -- -- -- --
Research & Development $3.13M $1.38M $2.24M $1.95M $3.75M $2.31M $2.81M $2.38M $789K $1.03M
Total Operating Expenses $13.41M $7.27M $8.73M $8.65M $8.58M $8.35M $6.13M $6.33M $3.49M --
Operating Income -$13.36M -$7.26M -$8.73M -$8.65M -$8.56M -$8.35M -$6.13M -$6.33M -$3.49M -$3.06M
EBITDA -- -- -- -$8.65M -$8.56M -$8.35M -$6.13M -$6.31M -$3.47M -$3.03M
Interest Expense -- $24K $13K $45K $98K -- -- -- -$35K -$2.4K
Net Income -$13.38M -$7.78M -$8.75M -$8.76M -$9.11M -$11.51M -$14.64M -$10.04M -$6.06M -$5.79M
Basic EPS -- -- -- -- -$0.02 -$0.04 -$0.09 -$0.07 -$0.05 -$0.04
Diluted EPS -$4.23 -$4.60 -- -- -$0.02 -$0.04 -$0.09 -$0.07 -$0.05 -$0.04
Basic Shares Outstanding -- -- -- -- 406.2M 276.4M 156.7M 139.2M 133.8M 130.9M
Diluted Shares Outstanding 3.2M 1.7M -- -- 406.2M 276.4M 156.7M 139.2M 133.8M 130.9M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue $66K $53K $0 $90K $32K $0 $36K $12K
Cost of Revenue $44K $35K $0 $63K $22K $0 $23K $7.7K
Gross Profit $21K $18K $0 $27K $9.4K $0 $13K $4.1K
Research & Development $203K $480K $2.77M $243K $326K $2.25M $313K $312K
Total Operating Expenses $1.04M $1.65M $4.21M $1.62M $2.27M $8.23M $1.29M $1.90M
Operating Income -$1.02M -$1.63M -$4.21M -$1.60M -$2.26M -$8.23M -$1.28M -$1.90M
Interest Expense $13K $7.4K $2.4K -- $8.6K $6.8K $2.6K -$44K
Income Tax Expense -- -- -- -- $0 $0 $0 --
Net Income -$1.03M -$1.64M -$4.21M -$1.60M -$2.27M -$8.24M -$1.28M -$1.91M
Diluted EPS -$0.27 -$0.43 -$1.12 -- -$0.67 -$2.78 -$0.47 --
Diluted Shares Outstanding 3.8M 3.8M 3.8M -- 3.4M 3.0M 2.7M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents -- -- $1.80M $8.90M $138K $346K $389K $317K $507K $17K
Cash & Short-Term Investments -- -- $1.80M $8.90M $138K $346K $389K $317K $507K $17K
Accounts Receivable, Net $2.2K $3.7K $0 -- -- $0 -- -- -- --
Total Current Assets $1.64M $425K $1.90M $8.96M $168K $369K $412K $332K $520K $29K
Property, Plant & Equipment, Net -- $0 $0 $0 $0 $0 $0 $0 $19K $44K
Total Non-Current Assets $7.7K $130K $221K $30K $52K $0 $0 $0 $198K $44K
Total Assets $1.64M $556K $2.12M $8.99M $220K $369K $412K $332K $737K $73K
Accounts Payable $547K $993K $491K $654K $1.56M $1.37M $422K $542K $666K $1.11M
Total Current Liabilities $2.04M $2.76M $2.03M $2.95M $11.39M $8.71M $22.69M $4.56M $11.18M $4.97M
Total Non-Current Liabilities $116K $0 $106K $0 $137K $0 $0 $12.08M $3.18M $4.60M
Total Liabilities $2.16M $2.76M $2.13M $2.95M $11.53M $8.71M $22.69M $16.64M $14.36M $9.57M
Total Debt (incl. Leases) -- $106K $205K $15K $60K -- -- -- -- --
Common Stock $3.6K $2.4K $1.6K $9.4K $5.2K $397K $180K $141K $137K $132K
Retained Earnings -$137.0M -$123.6M -$115.8M -$107.1M -$99.06M -$89.96M -$78.45M -$63.81M -$53.77M -$47.71M
Total Stockholders' Equity -$515K -$2.21M -$11K $6.04M -$11.31M -$8.34M -$22.28M -$16.30M -$13.62M -$9.50M
Total Equity -$515K -$2.21M -$11K $6.04M -$11.31M -$8.34M -$22.28M -$16.30M -$13.62M -$9.50M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Accounts Receivable, Net $0 $34K $0 $2.2K $28K $0 $3.7K $3.7K
Total Current Assets $281K $410K $1.02M $1.64M $437K $495K $711K $425K
Property, Plant & Equipment, Net -- -- -- -- -- -- -- $0
Total Non-Current Assets $278K $293K $308K $7.7K $59K $80K $106K $130K
Total Assets $559K $703K $1.33M $1.64M $496K $576K $816K $556K
Accounts Payable $993K $861K $655K $547K $788K $1.09M $706K $993K
Total Current Liabilities $3.61M $2.96M $2.61M $2.04M $2.58M $2.87M $3.09M $2.76M
Total Non-Current Liabilities $232K $284K $336K $116K $0 $0 $0 $0
Total Liabilities $3.85M $3.24M $2.95M $2.16M $2.58M $2.87M $3.09M $2.76M
Total Debt (incl. Leases) $286K $301K $315K -- $22K $51K $79K $106K
Common Stock $3.8K $3.8K $3.8K $3.6K $3.5K $3.3K $2.8K $2.4K
Retained Earnings -$143.9M -$142.8M -$141.2M -$137.0M -$135.4M -$133.1M -$124.9M -$123.6M
Total Stockholders' Equity -$3.29M -$2.54M -$1.62M -$515K -$2.08M -$2.30M -$2.27M -$2.21M
Total Equity -$3.29M -$2.54M -$1.62M -$515K -$2.08M -$2.30M -$2.27M -$2.21M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$13.38M -$7.78M $8.75M -$8.76M -$9.11M -$11.51M -$14.64M -$10.04M -$6.06M -$5.79M
Depreciation & Amortization -- -- -- $0 $0 $0 $0 $19K $25K $25K
Stock-Based Compensation $1.51M $90K -$298K -$105K $1.25M $3.61M $88K $2.49M $1.20M --
Change in Receivables $1.5K -$3.7K $0 -- -- -- -- -- -- --
Change in Payables -$446K $502K -$164K -$905K $187K $950K -$119K -$125K -$448K -$21K
Operating Cash Flow -$4.31M -$5.80M -$7.10M -$6.80M -$2.59M -$3.71M -$5.01M -$4.24M -$2.54M -$2.30M
Investing Cash Flow $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Common Stock Issued $5.60M $485K $0 $1.51M $401K $2.65M $3.43M $0 -- --
Financing Cash Flow $5.58M $4.28M $0 $15.57M $2.38M $3.66M $5.08M $4.05M $3.03M $2.31M
Net Change in Cash $1.27M -$1.52M -$7.10M $8.76M -$208K -- -- -- $490K $15K

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Net Income -$1.03M -$1.64M -$4.21M -$1.60M -$2.27M -$8.24M -$1.28M -$1.91M
Change in Receivables -- -- $2.2K $26K -$28K $3.7K $0 --
Change in Payables $132K $206K $108K -$241K -$306K $388K -$287K $602K
Operating Cash Flow -$267K -$476K -$1.43M -$906K -$1.09M -$624K -$1.70M -$716K
Investing Cash Flow $0 $0 $0 $0 $0 $0 $0 $0
Common Stock Issued $245K $150K -- $2.42M $1.41M $1.63M $131K --
Financing Cash Flow $314K -$31K $405K $2.29M $1.24M $487K $1.56M -$495K
Net Change in Cash $47K -$507K -$1.03M $1.38M $157K -$136K -$136K -$1.21M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 31.1% 42.0% -- -- -- -- -- -- -- --
Operating Margin -8498.9% -26267.7% -- -- -42778.4% -- -- -- -- --
Net Profit Margin -8513.4% -28127.2% -- -- -45528.6% -- -- -- -- --
Return on Equity (ROE) -- -- -- -144.9% -- -- -- -- -- --
Return on Assets (ROA) -814.6% -1399.5% -411.9% -97.4% -4135.6% -3116.0% -3556.5% -3021.1% -821.9% -7965.2%
Current Ratio 0.80x 0.15x 0.94x 3.04x 0.01x 0.04x 0.02x 0.07x 0.05x 0.01x
Quick Ratio -- -- 0.89x 3.02x 0.01x 0.04x 0.02x 0.07x 0.05x 0.00x
Debt to Equity -- -- -- 0.00x -- -- -- -- -- --
Revenue Growth (YoY) +468.6% -- -- -100.0% -- -- -- -- -- --
Gross Profit Growth (YoY) +321.6% -- -- -- -- -- -- -- -- --
Net Income Growth (YoY) -- -- -- -- -- -- -- -- -- -950.3%
EPS Growth (YoY) -- -- -- -- -- -- -- -- -- -500.0%
5Y Net Income / Share Growth -- -- -- -- -- -866.6% -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Gross Margin 31.7% 31.1% 30.0% 31.1% 33.0% 35.0% 38.0% 42.0%
Operating Margin -4045.7% -5544.9% -13411.4% -8498.9% -17289.4% -21871.9% -10365.6% -26267.7%
Net Profit Margin -4059.7% -5558.3% -13430.1% -8513.4% -17327.3% -22333.7% -11176.5% -28127.2%
Return on Assets (ROA) -1516.8% -1382.2% -1225.7% -814.6% -2762.8% -2301.7% -867.5% -1399.5%
Current Ratio 0.08x 0.14x 0.39x 0.80x 0.17x 0.17x 0.23x 0.15x
Revenue Growth (YoY) +108.3% -- -100.0% +662.7% +166.9% -100.0% -- --
Gross Profit Growth (YoY) +125.3% -- -100.0% +553.6% +128.8% -100.0% -- --
Source: SEC EDGAR CompanyFacts (CIK 0001101026) · from September 30, 2010 Data through September 30, 2025 · synced Nov 21, 2026, 05:03 UTC · Open in terminal